Triple combination cystic fibrosis transmembrane receptor modulator effects on glycaemia and insulin kinetics in cystic fibrosis with and without diabetes [0.03%]
囊性纤维化跨膜调节物联合用药对囊性纤维化（有糖尿病和无糖尿病）患者血糖和胰岛素动力学的影响
Yi W Chen,Rachel Prasad,Peter G Middleton et al.
Yi W Chen et al.
Background: Greater insight into the effects of cystic fibrosis (CF) transmembrane modulators such as elexacaftor-tezacaftor-ivacaftor (ETI) on glucose metabolism can support a more dynamic and individualised approach to ...
Practical considerations of ward-based high-flow nasal oxygen therapy for hypoxaemic respiratory failure [0.03%]
高流量鼻导管氧疗在呼吸衰竭病房管理中的实践问题
Isaac K S Ng,An Jian Leung,Wilson G W Goh
Isaac K S Ng
A multidisciplinary algorithmic approach to psoriasis with cardiovascular comorbidities: integrating dermatology, internal medicine, cardiology and primary care [0.03%]
一种多学科的算法方法治疗心血管合并症银屑病患者：融合皮肤病学、内科、心脏病学和初级保健
Gustavo Almeida-Silva,João Ferreira,Daniel Costa Gomes et al.
Gustavo Almeida-Silva et al.
A prospective study of 12-month survival of patients with cirrhosis admitted to intensive care [0.03%]
肝硬化患者入住重症监护室的12个月生存率预测研究
Minnie Au,Xian J Mah,Sern W Yeoh et al.
Minnie Au et al.
Background: The assessment on whether to escalate care in patients with cirrhosis to the intensive care unit (ICU) is complex, with little data on long-term outcomes. The primary aim of this study was to prospectively exa...
Key predictors of carpal tunnel syndrome: insights from a large electrophysiologically confirmed cohort [0.03%]
基于大样本电生理确诊队列探究腕管综合征的主要危险因素
Aydan Koysuren,Aytekin Osmanbeyoglu,Selcen Duran et al.
Aydan Koysuren et al.
Objective: We evaluated the relationships between demographic, metabolic and biochemical risk factors and the presence, localisation and severity of carpal tunnel syndrome (CTS) in a large Turkish cohort. ...
When to consider an inborn error of immunity: clues for physicians [0.03%]
inherited immune缺陷疾病的临床线索
Meera Thangarajah,Lucinda J Berglund
Meera Thangarajah
The term inborn errors of immunity (IEIs) refers to the rapidly expanding group of genetic disorders causing dysregulation of the immune system. With improved genetic testing in recent years, the number of defined IEIs and their range of ph...
Quality in Australian Health Care Study 2: a national imperative for safer care [0.03%]
澳大利亚医疗质量研究（第二阶段）：确保医疗安全的全国性任务
Peter D Hibbert,Johanna I Westbrook,Jeffrey Braithwaite
Peter D Hibbert
We argue for and outline the design of a second Quality in Australian Health Care Study (QAHCS2), 30 years after the original landmark study. A narrative review of historical developments in Australian patient safety since the publication o...
The role and uptake of drug and alcohol services in patients with alcohol-associated acute pancreatitis at a large multisite health service [0.03%]
大型多点医疗服务中酒精性急性胰腺炎患者的药物和酒精服务的作用及接受情况
Cindy Ho,Hardesh Dhillon,Alexander Mitropoulos et al.
Cindy Ho et al.
Background: Alcohol consumption remains an independent risk factor for recurrent presentations of alcohol-associated acute pancreatitis (AAP). Although there are recognised guidelines for alcohol use disorder (AUD), there...
Medication discontinuation in the era of elexacaftor/tezacaftor/ivacaftor: an Australian survey and qualitative interview [0.03%]
关于艾拉卡伐托尔/泰扎卡托尔/伊维考托尔时代的药物停用：一项澳大利亚调查和定性访谈
Matthew Corbett,Bandana Saini,Anna Dunn et al.
Matthew Corbett et al.
Chloride channel potentiator and corrector elexacaftor/tezacaftor/ivacaftor (ETI) has reduced the burden of disease in people with cystic fibrosis (PwCF) and led to some patients ceasing high-burden treatment regimens. This study was a pros...